Mini-Reviews in Medicinal Chemistry

Top Research Topics at Mini-reviews in Medicinal Chemistry?

The objective of Mini-reviews in Medicinal Chemistry is to combine knowledge in the areas of Pharmacology, Biochemistry, Drug, Combinatorial chemistry and Cancer research. Some problems in Pharmacology that were presented in the journal overlapped with concepts under Receptor, Disease, In vivo and Drug discovery. Enzyme, Structure–activity relationship and Antioxidant are some of the study areas of Biochemistry discussed.

The in-depth study on Cancer research also explores topics in the intersecting field of Cancer. The Cancer study tackling the subject of Cancer cell is the focus of it.

• Pharmacology (23.08%)
• Biochemistry (15.14%)
• Drug (8.40%)

What are the most cited papers published in the journal?

• Distribution and biological activities of the flavonoid luteolin. (660 citations)
• A review on the dietary flavonoid kaempferol. (650 citations)
• The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes. (579 citations)

Research areas of the most cited articles at Mini-reviews in Medicinal Chemistry:

The published articles investigate studies in Pharmacology, Biochemistry, Structure–activity relationship, Combinatorial chemistry and Stereochemistry. The Pharmacology research presented in the most cited publications focuses mostly on Cancer research and, on occasion, topics in Carcinogenesis. Aside from discussions in Biochemistry, the most cited publications also deal with the subject of In vivo which intersects with In vitro disciplines.

What topics the last edition of the journal is best known for?

• Enzyme
• Gene
• Internal medicine

The previous edition focused in particular on these issues:

Mini-reviews in Medicinal Chemistry generally zeroes in on subjects such as Pharmacology, Drug, Traditional medicine, Disease and Combinatorial chemistry. While Pharmacology is the key highlight in it, it also covered some subjects on Diabetes mellitus and Insulin. The studies on Disease discussed can also contribute to research in the domains of Clinical trial, Neuroscience and Intensive care medicine.

Some problems in Combinatorial chemistry that were presented in it overlapped with concepts under Mechanism of action, Moiety, Pharmacophore, Biological activity and Drug discovery. The journal explores research in Antimicrobial and overlapping concepts in Biochemistry to expand the discourse in Biological activity. While work presented in it provided substantial information on Drug discovery, it also covered topics in Cancer and Computational biology.

The most cited articles from the last journal are:

• Biological Nanofactories: Using Living Forms for Metal Nanoparticle Synthesis. (28 citations)
• An Insight in Pathophysiological Mechanism of Alzheimer's Disease and its Management Using Plant Natural Products. (5 citations)
• G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Mini-reviews in Medicinal Chemistry (based on the number of publications) are:

• Kamil Kuca (18 papers) absent at the last edition,
• Hai-Liang Zhu (11 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• Thoraya A. Farghaly (10 papers) absent at the last edition,
• Miroslav Pohanka (10 papers) published 2 papers at the last edition the same number as at the previous edition,
• Amirhossein Sahebkar (9 papers) published 3 papers at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Mini-reviews in Medicinal Chemistry (based on the number of publications) are:

• Shandong University (37 papers) absent at the last edition,
• University of Calabria (24 papers) absent at the last edition,
• Cairo University (21 papers) absent at the last edition,
• University of Porto (17 papers) published 1 paper at the last edition the same number as at the previous edition,
• Islamic Azad University (17 papers) published 4 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.20% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 5.61% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.89% of all publications and 73.83% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.